TABLE 2.
Gene | Gene product nameb | Relative change in gene expression in cells with indicated genotypea
|
||
---|---|---|---|---|
RK−/− | Gα12−/− | Gα13−/− | ||
Antioxidant enzyme genes | ||||
Hmox1 | Heme oxygenase (decycling) 1 | 9.90 | 13.11 | 11.59* |
Txnrd1 | Thioredoxin reductase 1 | 1.50** | 5.97*† | 2.19* |
Gsr | Glutathione reductase 1 | 1.16 | 2.85*† | 2.13* |
Cat | Catalase | 1.18 | 2.20* | 1.38** |
Prdx1 | Peroxiredoxin 1 | 1.27 | NA | 1.56 |
Xenobiotic metabolism genes | ||||
Nqo1 | NAD(P)H dehydrogenase quinone 1 | 4.32 | 16.01** | 3.13** |
Gclm | Glutamate-cysteine ligase modifier subunit | 2.30* | 10.39**‡ | 2.22** |
Gclc | Glutamate-cysteine ligase catalytic subunit | 2.16* | 9.72**‡ | 3.27**† |
Gsta4 | GlutathioneS-transferase alpha 4 | 3.64* | 7.27**† | 3.69** |
Gsta3 | Glutathione S-transferase alpha 3 | NA | 5.51 | 1.13 |
Gsta2 | GlutathioneS-transferase alpha 2 (Yc2) | 1.10 | 3.43*† | 2.71*‡ |
Gstp1 | Glutathione S-transferase pi 1 | 1.37* | 2.40 | 1.43* |
Gss | Glutathione synthetase | 1.39 | 2.31 | 1.37* |
Gsto1 | Glutathione S-transferase omega 1 | 1.87** | 1.84 | 1.66* |
Gstm3 | Glutathione S-transferase mu 3 | 1.51 | 1.82* | 1.88** |
Gstm1 | GlutathioneS-transferase mu 1c | 2.60** | 1.54† | 3.00** |
UGT1A6 | UDP glycosyltransferase 1 family A6d | 2.98** | 1.40† | 2.55**† |
Nqo2 | NAD(P)H dehydrogenase quinone 2 | 1.62* | 1.19 | 1.21 |
Mgst1 | Microsomal glutathione S-transferase 1 | 2.07* | 1.15 | 1.84* |
Gstm4 | Glutathione S-transferase mu 4 | 1.09 | 1.14 | 0.94† |
Gstk1 | Glutathione S-transferase kappa 1 | 0.91 | 1.09 | 0.86 |
Gstm5 | Glutathione S-transferase mu 5 | 1.03 | 0.93 | 1.03 |
Mgst3 | Microsomal glutathione S-transferase 3 | 1.03 | 0.92 | 1.21 |
Gstm6 | Glutathione S-transferase mu 6 | 1.43 | 0.84 | 1.29* |
Gstz1 | Glutathione S-transferase zeta 1 | 0.95 | 0.82 | 0.87 |
Gstm2 | Glutathione S-transferase mu 2 | 1.52 | 0.66 | 1.25* |
Gstt3 | Glutathione S-transferase theta 3 | 1.33 | 0.65 | NA |
Gstt1 | Glutathione S-transferase theta 1 | 0.78** | 0.50 | 0.81 |
Each value indicates the relative change after t-BHQ treatment (30 μM, 12 h). Asterisks indicate significant difference from value for vehicle treatment (*, P < 0.05; **, P < 0.01). Daggers indicate significant difference from RK−/− values (†, P < 0.05; ‡, P < 0.01). NA, data not available.
Genes for products in bold are Nrf2 dependent.
Basal mRNA content was 2.4-fold greater in Gα12−/− cells than in control cells.
Basal mRNA content was 42-fold greater in Gα12−/− cells than in control cells.